| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Mar, 2026 | Mar, 2026 |
| Sales | 93,060 | 270 | 0 | 0 | 0 |
| Sales Growth | +34,366.54% | unch | unch | unch | unch |
| Net Income | -64,830 | -37,350 | -8,470 | 0 | 0 |
| Net Income Growth | -73.57% | -340.97% | unch | unch | unch |
Lucira Health Inc (LHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.